Understanding Your Laboratory Test: What It Is, Why It Is Done, and What Your Results Mean
A genetic blood test that analyzes the ACVRL1 and ENG genes to help diagnose hereditary hemorrhagic telangiectasia (HHT), a condition affecting blood vessels.
{"This test looks for genetic mutations in the ACVRL1 and ENG genes associated with HHT","HHT causes abnormal blood vessel formation leading to nosebleeds, skin lesions, and potential organ complications","A simple blood sample is all that's needed for this genetic analysis","Results help confirm diagnosis and guide family screening decisions","Results typically take 2-4 weeks as specialized genetic testing is performed"}
Key facts at a glance
- LOINC
- 53837-1
- Short code
- ACVRL1 ENG MUT
- Synonyms
- ACVRL1+ENG gene Mut Anl Bld/T
- Category
- chemistry
- Sample
- whole-blood
- Container
- EDTA tube (purple top) or ACD tube
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- molgen
- CPT
- 81403
- SNOMED
- 22943007
- Specimen volume
- 3-5 mL whole blood
- Stability
- Room temperature: 72 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C or below): acceptable for extended storage
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 336–1008 hours
- Order
- routine
This is a laboratory test that measures specific substances in a sample of your blood, urine, or other body fluid. Your healthcare provider uses the results to check how well your body is working, screen for certain health conditions, or monitor a treatment plan that is already in place.
The ACVRL1 and ENG gene mutation analysis is a specialized genetic test that examines your DNA to look for specific changes (mutations) in two genes called ACVRL1 and ENG. These genes are known to cause Hereditary Hemorrhagic Telangiectasia (HHT), a genetic disorder that affects blood vessels throughout the body.
Your provider may order this test as part of a routine checkup, to help find the cause of symptoms you are having, to confirm or rule out a suspected condition, or to see how well a medicine or other treatment is working over time. Testing can also help detect problems early, before symptoms appear.
Your healthcare provider may recommend this test if you have symptoms suggesting HHT, such as frequent nosebleeds, tiny red or purple spots on your skin (telangiectasias), or a family history of the condition. The test can also help determine if family members should be screened for HHT, as this condition is inherited.
The test is usually done with a small sample of blood drawn from a vein in your arm using a thin needle. The site is cleaned first, and the draw takes only a few minutes. Some tests use a urine sample or a simple finger stick instead. Afterward, a small bandage is placed on the site and you can go about your day.
A healthcare professional will collect a small blood sample from a vein in your arm. This sample is then sent to a specialized laboratory where scientists extract your DNA and analyze the ACVRL1 and ENG genes for specific mutations. The process involves molecular genetics techniques to identify any disease-causing changes in these genes.
Your results are compared with a reference range, which is the range of values typically seen in healthy people. Values that fall inside this range are generally considered normal, while results that are higher or lower may point to a condition that needs a closer look. Your provider will explain what your specific numbers mean and whether any follow-up testing or treatment is needed.
If a mutation is found in either the ACVRL1 or ENG gene, it confirms a diagnosis of HHT. If no mutation is found but you have symptoms, your doctor may consider other causes or recommend additional testing. A negative result in someone with a family history of HHT may indicate the person did not inherit the family mutation.
Reference range
Negative / No pathogenic mutation detected in ACVRL1 and ENG genesN/A
No special preparation required. Informed consent for genetic testing may be required. Clinical history of hereditary hemorrhagic telangiectasia (HHT) symptoms should be provided including epistaxis, telangiectasias, AVM history, and family history.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
This test is crucial for confirming the diagnosis of Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome. HHT affects approximately 1 in 5,000-10,000 people and causes abnormal blood vessel formation. These abnormal vessels can lead to serious complications including internal bleeding, iron deficiency anemia, brain arteriovenous malformations (AVMs), lung AVMs, and liver AVMs. Early diagnosis through genetic testing allows for proper monitoring and treatment to prevent serious complications.
The test also has significant implications for family members. Since HHT is an autosomal dominant disorder (meaning children have a 50% chance of inheriting it if a parent has the condition), identifying the specific genetic mutation in one family member allows for targeted testing of other family members. This enables early intervention and regular screening for at-risk relatives.
Frequently asked questions
Is fasting required before this test?
How long does it take to get results?
Will my insurance cover this genetic test?
Does a negative result mean I don't have HHT?
Should my family members be tested?
What happens if I test positive for a mutation?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy